Novo Nordisk is a global healthcare company, headquartered in Denmark. Our key contribution is to discover and develop innovative biological medicines and make them accessible to patients throughout the world. We aim to lead in all disease areas in which we are active.
Our corporate strategy
Our corporate strategy has four distinct focus areas in which we operate. It is built on our purpose, the Novo Nordisk Way and our ambition to be a sustainable business. We aim to strengthen our leadership and treatment options in Diabetes and Obesity care, secure leading positions within Biopharm and establish a strong presence in other serious chronic diseases such as NASH, cardiovascular disease and Alzheimer’s disease. Succeeding in this will drive sustainable growth for Novo Nordisk.
Financial figures
140,800
DKK million in net sales
29,319
DKK million in free cash flow
58,644
DKK million in operating profit
Novo Nordisk facts
168
countries with marketed products
80
countries with affiliates
5
countries with R&D facilities
48,478
employees worldwide
